We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

DNMX:NASDAQDynamix Corporation III Analysis

Data as of 2026-06-21 - not real-time

$10.01

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Technical outlook: DNMX is trading at $10.01, just above its 20‑day SMA ($10.02) and comfortably above the 50‑day ($9.99) and 200‑day ($9.94) averages, indicating a modest bullish bias. The RSI sits at 53, suggesting neutral momentum, while the MACD histogram is slightly negative, signaling a bearish crossover in the short term. Volume has been decreasing, yet today’s volume (≈88k) exceeds the 10‑day average, hinting at limited buying pressure. The stock’s beta is virtually zero (0.01) and 30‑day volatility is low at 1.26%, resulting in a minimal max drawdown of less than 1%, and the market sentiment is in “Extreme Greed” (fear‑greed index 91.46).
Fundamental outlook: The company reports zero revenue, no earnings, and a negative book value per share (-$0.27), yielding a nonsensical price‑to‑book of -37.2. It carries no debt, no cash flow generation, and pays no dividend. As a shell entity focused on future mergers, the valuation is highly speculative with no intrinsic earnings support, making the current price appear overvalued relative to its financial reality.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 5/10

Key Factors

  • Price marginally above short‑term moving averages
  • Neutral RSI with bearish MACD crossover
  • Decreasing volume trend

Medium Term

1–3 years
Neutral
Model confidence: 4/10

Key Factors

  • Absence of revenue, earnings, and cash flow
  • Negative book value and meaningless valuation multiples
  • Regulatory and merger‑execution uncertainty

Long Term

> 3 years
Positive
Model confidence: 6/10

Key Factors

  • Potential value creation from a future merger or business combination
  • Low volatility and near‑zero beta reducing market‑wide risk
  • Current market sentiment in extreme greed supporting speculative upside

Key Metrics & Analysis

Financial Health

P/B Ratio-37.2
Op. Cash Flow$-763846
Industry P/E16.9

Technical Analysis

TrendBullish
RSI52.8
Support$10.00
Resistance$10.03
MA 20$10.02
MA 50$9.99
MA 200$9.94
MACDBearish
VolumeDecreasing
Fear & Greed Index91.46

Valuation

GradeOvervalued
TypeBlend

Risk Assessment

Beta0.01
Volatility1.26%
Sector RiskMedium
Reg. RiskHigh
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.